PFIZER INC — Director's Dealing 2011

Sep 16, 2011

SEC Form 4/A — Form 4/A

Issuer: ICAGEN INC (ICGN)
CIK: 0000902622
Period of Report: 2011-09-02

Reporting Person: PFIZER INC (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-09-02	Common Stock	P	4611921	$6	Acquired	4611921	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1067015	Direct

Footnotes

F1: This filing is being amended to adjust the number of shares of Common Stock (hereinafter defined) acquired as reported in Table I, Box 4 and the number of shares of Common Stock beneficially owned as reported in Table I, Box 5 which were previously reported as 4,617,045. The adjusted amount for each of Box 4 and Box 5 of Table I is 4,611,921.

F2: This adjustment results from the failure of certain shareholders to deliver 5,124 shares of Common Stock tendered pursuant to notices of guaranteed delivery, as executed in conjunction with a tender offer by Eclipse Acquisition Corp. ("Purchaser"), a wholly-owned subsidiary of Pfizer Inc. ("Parent"), for all of the issued and outstanding common stock, $0.001 par value per share (the "Common Stock") of Icagen, Inc.

F3: Includes 1,067,015 shares previously directly owned by Parent.